As the first report of pyroptosis-related genes in PCa, this study accurately and effectively classified the risk of PCa patients by constructing a signature, which could predict the BCR and sensitivity to chemotherapy, endocrine therapy, and immunotherapy for PCa patients at different risk groups. Here, BCR is linked to posterior cortical atrophy.